Effects and mechanism of Tenglong Buzhong Decoction on anoikis of LoVo colorectal cancer cells
-
摘要: 目的 观察藤龙补中汤对人大肠癌LoVo细胞失巢凋亡的作用及机制。方法 将藤龙补中汤作用于悬浮生长的LoVo细胞,CCK-8试剂检测细胞增殖;试剂盒检测失巢凋亡、Caspases活性和活性氧;Western blot检测蛋白表达和磷酸化。结果 藤龙补中汤可以抑制LoVo细胞悬浮生长,诱导失巢凋亡,活化Caspase-3、Caspase-8和Caspase-9。Caspases抑制剂Z-VAD-FMK可拮抗藤龙补中汤对失巢凋亡的作用。藤龙补中汤可以上调活性氧生成,活性氧清除剂N-乙酰-L-半胱氨酸可拮抗藤龙补中汤对Caspases的作用。藤龙补中汤还可降低整合素αV和β3的表达,抑制黏着斑激酶的磷酸化。结论 藤龙补中汤可诱导LoVo细胞失巢凋亡,其机制可能与上调活性氧、下调整合素αV和β3的表达、抑制黏着斑激酶的磷酸化相关。Abstract: Objective To study the effects and mechanism of Tenglong Buzhong Decoction(TBD) on anoikis in human colorectal cancer LoVo cells.Methods Suspension grown LoVo cells were treated with TBD. Cell proliferation was detected by cell counting kit-8(CCK-8) assay. Anoikis, Caspases activaties and reactive oxygen species(ROS) were measured by commercial kit. Proteins expression and phosphorylation were identified by Western blot.Results TBD inhibited suspension growth of LoVo cells, induced anoikis and activated Caspase-3, Caspase-8, and Caspase-9. Caspases inhibitor Z-VAD-FMK antagonized the effects of TBD on anoikis. TBD up-regulated ROS, ROS scavenger N-acetyl-L-cysteine(NAC) attenuated the effects of TBD on Caspases. TBD also inhibited the expressions of integrin aV and β3, and phosphorylation of focal adhesion kinase(FAK).Conclusion TBD induces anoikis in LoVo cells, and may be related to up-regulation of ROS, and inhibition of integrin aV and integrin β3 expressions, and FAK phosphorylation.
-
[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
[2] Leowattana W, Leowattana P, Leowattana T. Systemic treatment for metastatic colorectal cancer[J]. World J Gastroenterol, 2023, 29(10): 1569-1588. doi: 10.3748/wjg.v29.i10.1569
[3] Khan SU, Fatima K, Malik F. Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis[J]. Clin Exp Metastasis, 2022, 39(5): 715-726. doi: 10.1007/s10585-022-10172-9
[4] 宝乐日, 卢艳琳, 蔡芸芸, 等. 藤龙补中汤维持治疗对大肠癌转移抑制作用的临床研究[J]. 中国中西医结合消化杂志, 2022, 30(7): 505-507, 513. https://zxyxh.whuhzzs.com/article/doi/10.3969/j.issn.1671-038X.2022.07.08
[5] 李淼, 王双双, 郑佳露, 等. 藤龙补中汤对SW620大肠癌转移和Wnt/β-catenin通路蛋白表达的影响[J]. 中华中医药杂志, 2022, 37(7): 4083-4085. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202207092.htm
[6] 王双双, 黄晓伟, 李淼, 等. 藤龙补中汤对大肠癌转移和整合素-FAK-ERK1/2通路蛋白表达的影响[J]. 中华中医药杂志, 2020, 35(4): 1697-1699. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202004021.htm
[7] 胡兵, 沈克平, 史秀峰, 等. 藤梨根对RKO结肠癌细胞失巢凋亡的作用[J]. 中国实验方剂学杂志, 2013, 19(16): 242-245. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201316074.htm
[8] 胡兵, 沈克平, 史秀峰, 等. 蛇莓对人结肠癌RKO细胞失巢凋亡作用的实验研究[J]. 世界中西医结合杂志, 2013, 8(1): 69-72. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZX201301028.htm
[9] Hu B, An HM, Wang SS, et al. Teng-Long-Bu-Zhong-Tang induces p21-dependent cell senescence in colorectal carcinoma LS174T cells via histone acetylation[J]. J Exp Pharmacol, 2017, 9: 67-72. doi: 10.2147/JEP.S129272
[10] 黄晓伟, 安红梅, 胡兵. 现代解毒抗癌中药治疗大肠癌研究进展[J]. 环球中医药, 2018, 11(11): 1838-1842. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY201811060.htm
[11] Yang HL, Kuo YH, Smith ZI, et al. Targeting cancer metastasis with antibody therapeutics[J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2021, 13(4): e1698. doi: 10.1002/wnan.1698
[12] Chhichholiya Y, Suman P, Singh S, et al. The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies[J]. Med Oncol, 2021, 38(8): 95. doi: 10.1007/s12032-021-01547-1
[13] Mina LA, Sledge GW Jr. Rethinking the metastatic cascade as a therapeutic target[J]. Nat Rev Clin Oncol, 2011, 8(6): 325-332. doi: 10.1038/nrclinonc.2011.59
[14] Liu JB, Lu GZ, Liang C, et al. Roles of anoikis in colorectal cancer therapy and the assessment of anoikis-regulatory molecules as therapeutic targets[J]. Pathol Res Pract, 2023, 241: 154256. doi: 10.1016/j.prp.2022.154256
[15] Sattari F, Jalilzadeh N, Mehdizadeh A, et al. Understanding and targeting anoikis in metastasis for cancer therapies[J]. Cell Biol Int, 2023, 47(4): 683-698.
[16] Yu L, Wang X, Du Y, et al. FASN knockdown inhibited anoikis resistance of gastric cancer cells via P-ERK1/2/bcl-xL pathway[J]. Gastroenterol Res Pract, 2021, 2021: 6674204.
[17] Zheng JL, Wang SS, Shen KP, et al. Ursolic acid induces apoptosis and anoikis in colorectal carcinoma RKO cells[J]. BMC Complement Med Ther, 2021, 21(1): 52.
[18] Adeshakin FO, Adeshakin AO, Afolabi LO, et al. Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming[J]. Front Oncol, 2021, 11: 626577.
[19] Hu B, Zhang T, An HM, et al. Herbal formula YGJDSJ inhibits anchorage-independent growth and induces anoikis in hepatocellular carcinoma Bel-7402 cells[J]. BMC Complement Altern Med, 2018, 18(1): 17.
[20] Chen JX, Lou Q, He L, et al. Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells[J]. Int J Oncol, 2018, 52(3): 1023-1032.
[21] Cai J, Niu X, Chen YY, et al. Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis[J]. Neoplasia, 2008, 10(1): 41-51.
[22] Tapial Martinez P, Lopez Navajas P, Lietha D. FAK structure and regulation by membrane interactions and force in focal adhesions[J]. Biomolecules, 2020, 10(2): 179.
[23] Fan Z, Duan J, Wang L, et al. PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling[J]. Cancer Lett, 2019, 450: 132-143.
[24] Chuang HH, Zhen YY, Tsai YC, et al. FAK in cancer: from mechanisms to therapeutic strategies[J]. Int J Mol Sci, 2022, 23(3): 1726.
[25] Tai YL, Chen LC, Shen TL. Emerging roles of focal adhesion kinase in cancer[J]. Biomed Res Int, 2015, 2015: 690690.
[26] Tvaroska I, Kozmon S, Kona J. Molecular modeling insights into the structure and behavior of integrins: a review[J]. Cells, 2023, 12(2): 324.
[27] Ha SY, Shin J, Kim JH, et al. Overexpression of integrin αv correlates with poor prognosis in colorectal cancer[J]. J Clin Pathol, 2014, 67(7): 576-581.
[28] Sun CC, Zargham R, Shao Q, et al. Association of CD98, integrin β1, integrin β3 and Fak with the progression and liver metastases of colorectal cancer[J]. Pathol Res Pract, 2014, 210(10): 668-674.
[29] Hasnat MA, Pervin M, Lim JH, et al. Apigenin attenuates melanoma cell migration by inducing anoikis through integrin and focal adhesion kinase inhibition[J]. Molecules, 2015, 20(12): 21157-21166.
[30] Duxbury MS, Ito H, Zinner MJ, et al. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells[J]. Surgery, 2004, 135(5): 555-562.